WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NURO), a health-care company that develops wearable medical technology and point-of-care tests, reported that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Rodman & Renshaw 17th Annual Global Investment Conference on September 10, 2015 at 3:25 pm EDT. Dr. Gozani intends to provide an update on the Company’s business activities including the Quell™ Wearable Pain Relief device.
A live audio webcast will be available on the investor relations section of the NeuroMetrix corporate website at http://www.NeuroMetrix.com/ and will be archived after the event.
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.